Mesoblast Ltd ADR (MESO) poses a Brand-New Opportunity for Investors with beta value of 3.56

Witnessing the stock’s movement on the chart, on Wednesday, Mesoblast Ltd ADR (NASDAQ: MESO) had a quiet start as it plunged -4.10% to $6.32, before settling in for the price of $6.59 at the close. Taking a more long-term approach, MESO posted a 52-week range of $1.61-$10.24.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The Healthcare sector firm’s twelve-monthly sales growth has been 5.23% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -7.89%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 4.96%. This publicly-traded company’s shares outstanding now amounts to $85.82 million. The organization now has a market capitalization sitting at $720.48 million. At the time of writing, stock’s 50-day Moving Average stood at $2.43, while the 200-day Moving Average is $3.48.

Mesoblast Ltd ADR (MESO) Earnings and Revenue Records

As on 6/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.28 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.31) by $0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.

Mesoblast Ltd ADR’s EPS increase for this current 12-month fiscal period is 4.96% and is forecasted to reach -0.85 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 48.80% through the next 5 years, which can be compared against the -7.89% growth it accomplished over the previous five years trading on the market.

Mesoblast Ltd ADR (NASDAQ: MESO) Trading Performance Indicators

Let’s observe the current performance indicators for Mesoblast Ltd ADR (MESO). It’s Quick Ratio in the last reported quarter now stands at 2.71. The Stock has managed to achieve an average true range (ATR) of 0.62. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 93.45.

In the same vein, MESO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.06, and analysts are predicting that it will be -0.85 at the market close of one year from today.

Technical Analysis of Mesoblast Ltd ADR (MESO)

Going through the that latest performance of [Mesoblast Ltd ADR, MESO]. Its last 5-days volume of 8.2 million indicated improvement to the volume of 2.1 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 80.60% While, its Average True Range was 0.80.

Raw Stochastic average of Mesoblast Ltd ADR (MESO) in the period of the previous 100 days is set at 81.91%, which indicates a major rise in contrast to 80.41% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 287.03% that was higher than 133.21% volatility it exhibited in the past 100-days period.